elearning

Regístrese gratis y obtenga acceso ilimitado a nuestra extensa biblioteca de elearning
Gane puntos CME y realice un seguimiento de su actividad de aprendizaje con cientos de horas de educación médica continua.
Bookmark and Share

Cost of treatments with immune agents

This module covers the key factors influencing the financial impact of immunotherapy on the healthcare industry and how we can work towards reducing this financial impact.

This e-learning course is comprised of 15 modules providing an up-to-date resource for medical professionals who seek to understand the latest research, advances in technology and future directions of immuno-oncology. Developed by ecancer in collaboration with King’s College London aimed at medical professionals interested in the field of immuno-oncology.

Published May 2019.

Cost of treatments with immune agents
Modulo
English
0 CME Points

Público destinatarios

This module is aimed at medical professionals interested in the field of immuno-oncology.

Objetivos educativos

By the end of this module, you will be able to:

  • Name the five current value frameworks and their limitations
  • Define the difference between value vs cost
  • Understand the perspectives of the patient, payer, and industry

Requisitos del sistema

This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.

If you are experiencing technical difficulties, please contact education@ecancer.org and we will get back to you as soon as possible.

Política de divulgación

ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from the Bristol-Myers Squibb Foundation and AbbVie Inc.

Both the BMS Foundation and AbbVie Inc. have had no input in the creation of the e-learning materials including the process of selecting speakers.

For more information, please email education@ecancer.org

Soporte

Production of this module was funded by an unrestricted grant from Bristol-Myers Squibb Foundation and AbbVie Inc.